Overview

Study of Cingalâ„¢ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide

Status:
Completed
Trial end date:
2018-04-23
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-blind, parallel group, active comparator controlled trial to evaluate the efficacy and safety of a single injection of Cingal for the relief of joint pain in subjects with OA of the knee.
Phase:
Phase 3
Details
Lead Sponsor:
Anika Therapeutics, Inc.
Treatments:
Hyaluronic Acid
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide